BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial Evaluating Topical ET-02 for the Treatment of Androgenic Alopecia

  Eirion Therapeutics Inc. announced today that the first participant has been enrolled in a Phase 1 clinical trial to evaluate the safety of the patented topical pharmaceutical ET-02 for the treatment of androgenic alopecia (age-related hair loss).

  July 1, 2024

   · 

  3 min read
• FDA

  Longboard Pharmaceuticals Receives Breakthrough Therapy Designation for Bexicaserin (LP352)

  U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for bexicaserin for the treatment of seizures associated with Developmental and Epileptic Encephalopathies (DEEs).

  July 1, 2024

   · 

  7 min read
• Press Releases

  Radionetics Oncology Enters Into Strategic Agreement With Lilly

  Radionetics Oncology announced today the formation of a strategic relationship with Eli Lilly and Company to take forward Radionetics’ proprietary GPCR targeting small molecule radiopharmaceuticals.

  July 1, 2024

   · 

  2 min read
• Business

  Advanced Bionics Announces New President and Management Board Member

  Advanced Bionics is pleased to announce the appointment of Alistair Simpson as its new president, and Group Vice President (GVP) for cochlear implants on the Sonova Management Board, effective immediately.

  July 1, 2024

   · 

  3 min read
• BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes

  BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (FSE: 8MV) (“BioHarvest” or the “Company”) has closed the first tranche of its private placement announced on June 21, 2024.

  July 1, 2024

   · 

  3 min read
• BioMidwest

  Anteris Technologies and v2vmedtech Announce Concept Lock of Next Generation Mitral and Tricuspid Repair System as VClip™ Passes Animal Study

  Anteris Technologies Ltd and v2vmedtech, inc. announced they have reached concept lock on the first phase of the system.

  July 1, 2024

   · 

  3 min read
• Business

  Fennec Pharmaceuticals Announces Management Change

  Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.

  July 1, 2024

   · 

  4 min read
• Policy

  Kanvas Biosciences Secures Additional $12.5M to Advance Its Novel, Microbiome-Based Immuno-oncology Drug Candidates to IND Filing

  Kanvas Biosciences, a full-stack spatial biology company, announced it has raised $12.5 million in additional funding co-led by existing investors DCVC and Lions Capital LLC, and participation from FemHealth Ventures, Germin8, Ki Tua Fund, and Pangaea Ventures as well as existing investors.

  July 1, 2024

   · 

  6 min read
• Business

  Cyrus Taraporevala Elected to Pfizer’s Board of Directors

  Pfizer Inc. announced the election of Cyrus Taraporevala to its Board of Directors, effective immediately.

  July 1, 2024

   · 

  2 min read
• Business

  Benitec Biopharma Announces Appointment of Kishen Mehta to its Board of Directors

  Benitec Biopharma Inc. today announces the appointment of Kishen Mehta to the board of directors (BOD) of the Company, effective June 26, 2024.

  July 1, 2024

   · 

  5 min read